Ingredion Incorporated research snapshot
INGR AI stock analysis reads Ingredion Incorporated as a steady, cash-generative corn wet milling and ingredient solutions company trading at a low multiple while it works through a transformative acquisition. At the August 4, 2026 cutoff, the most recent verified close was $99.46 on July 31, 2026, market capitalization was about $6.27 billion, and the stock was near the bottom of its 52-week range with a trailing P/E of about 9.5x and a dividend yield near 3.3%. Tate & Lyle shareholders accepted Ingredion's 595 pence all-cash offer on July 28, 2026, with closing expected in the second half of 2027 pending regulatory approvals, and Ingredion reports second quarter 2026 results on the data cutoff date. This is informational research and not investment advice.
Current price
$99.46
Market cap
$6.27 billion
AI score
63 / 100
Rating
Low-multiple cash generator with deal execution risk
Trend status
Ranging near the bottom of the 52-week band ahead of Q2 results and Tate & Lyle approval
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Ingredion processes corn and other plant-based materials into starches, sweeteners, and texture and healthful ingredients sold to food, beverage, pharma, personal care, and industrial customers. Demand is recurring and essential-use, but pricing power is limited by commodity cost pass-through and contract terms. | High |
| Moat | Scale moat from large wet-milling assets, a global distribution network, long customer relationships, and recipe-level switching costs in specialty ingredients. Commodity segments such as corn syrup and industrial starch face intense competition from Archer-Daniels-Midland, Cargill, and regional producers. | Medium-high |
| Management | Chairman and CEO Jim Zallie has led the company since 2017 and is executing the defining bet of his tenure: the roughly $3.6 billion all-cash offer for Tate & Lyle that shareholders accepted on July 28, 2026. Management keeps a $3.28 annual dividend, sold 51% of the Pakistan business for $165 million in June 2026, and added bolt-on assets such as the Benicaros prebiotic fiber. | Medium |
| Financial trend | TTM revenue of $7.2 billion was roughly flat, reflecting low organic growth. TTM net income was $674 million with a 9.36% profit margin, a 16.19% return on equity, and a 7.88% return on assets. Operating cash flow was about $900 million while TTM levered free cash flow was $357.75 million. Total debt to equity was 41.43% before the pending deal, which will add debt when it closes. | High |
| Valuation | INGR trades near 9.5x trailing earnings, 1.43x book value, and about 0.9x to 1.0x sales, below the broader market and packaged food peers. The low multiple reflects slow growth, commodity exposure, and deal execution risk. TTM free cash flow yield is about 5.7% and the dividend yield is about 3.3%. | Medium-high |
| Technical trend | INGR closed at $99.46 on July 31, 2026, near the $94.44 52-week low and roughly 24% below the $134.77 52-week high reported by Yahoo Finance (WallStreetZen lists the high at $130.48). The stock rose about 5% over the past month while staying down over six months, and recent volume has been below average. | Medium |
| Risk level | Risks include corn input cost volatility, integration and regulatory risk from the Tate & Lyle deal, higher debt after closing, foreign exchange exposure from significant international revenue, low organic growth, and concentration in mature packaged food end markets. | Medium-high |
| AI confidence | High confidence for filings, segment data, market cap math, and valuation ratios. Moderate confidence for near-term price direction because second quarter 2026 earnings land on the data cutoff date and the deal is still subject to regulatory approval. | High data confidence |
| Investment certainty | Medium. Ingredion is a durable cash generator at a reasonable price, but the investment case hinges on whether Tate & Lyle delivers the promised synergy and growth upgrade or adds complexity and debt without transformation. | Medium |
INGR AI stock forecast
The INGR AI stock forecast uses scenario ranges around the $99.46 reference price and does not claim that AI can predict a specific future price. The bullish case depends on the Tate & Lyle deal closing on time, synergy delivery near the $130 million run-rate target, and a specialty mix that lifts margins. The base case assumes steady single-digit EPS growth with the multiple holding near current levels. The bearish case assumes the deal struggles or breaks, corn prices spike, or organic growth stalls.
$150 to $180
More likely if the Tate & Lyle acquisition closes in the second half of 2027, net cost synergies near the $130 million run-rate target are delivered, specialty revenue lifts gross margins, and the market re-rates INGR toward 12x to 13x forward earnings.
$115 to $135
More likely if EPS grows at roughly 6% a year toward about $12.5 by 2028, the multiple holds near 10x forward earnings, the deal closes with standard execution, and corn costs stay manageable. This range is consistent with average analyst 12-month targets of about $121 to $124.
$70 to $95
More likely if the Tate & Lyle transaction faces regulatory delay or failure, integration problems push debt higher and synergies fall short, corn prices spike and crush margins contract, or organic revenue declines.
INGR AI technical analysis
INGR AI technical analysis starts from the $99.46 close on July 31, 2026 used for this page. The stock trades near the bottom of a 52-week range that has held since May 2026. Because this page does not fetch request-time market data, confirm levels on a live chart before trading. Yahoo Finance quotes were delayed during research, so the reference price is checked against WallStreetZen.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $99.46 | Most recent verified close on July 31, 2026, from WallStreetZen. Yahoo Finance showed a delayed July 28 close of $102.71. |
| Near support | $94 to $96 | The 52-week low area, with the low at $94.44. A daily close below this zone would be the first sign the range is breaking. |
| Secondary support | $85 to $88 | A multi-year base and a psychological zone. A sustained break below $94 could open a path toward it. |
| Near resistance | $104 to $110 | The late July swing high area and the declining moving averages. A close above this zone on rising volume would suggest trend repair. |
| Key resistance | $120 to $125 | The area around average analyst price targets and former 2025 support. Recovery above this level would signal a stronger trend change. |
| Momentum | Mixed | INGR rose about 5% over the past month but remains down over six months, reflecting chop rather than a clear trend. |
| Volume | About 432,000 shares versus an average near 906,000 | Recent volume has run below average, typical near range lows but without signs of heavy accumulation. |
| Volatility | Moderate to low | A beta of 0.61 (5-year monthly, Yahoo Finance) suggests INGR moves less than the market, while the 52-week range of $94 to $135 shows large absolute swings. |
| Invalidation | Daily close below $94.44 | A close below the 52-week low would invalidate the support framework; a sustained break below $85 would point to structural selling. |
INGR AI trading strategy
The INGR AI trading strategy is a rules-based framework, not personalized advice. It combines filing-backed fundamentals, technical confirmation, position sizing, and clear invalidation levels.
Watch for Tate & Lyle regulatory milestones and the second quarter 2026 earnings report released today. A bullish setup forms if INGR holds the $94 support zone and closes above $104 to $110 with above-average volume as deal clarity improves.
Do not buy only because the stock looks cheap; the discount exists for real reasons. Cut exposure if the price closes below $94 or if the deal faces regulatory rejection or financing trouble.
INGR pays a $3.28 annual dividend, about a 3.3% yield at the reference price. For income investors, monitor free cash flow coverage of the dividend and how acquisition debt changes payout capacity after closing.
The dividend payout is roughly half of TTM levered free cash flow. A dividend cut after the acquisition would break the income thesis.
Track the second quarter 2026 results released today, quarterly segment revenue, corn and energy input costs, gross and operating margins, the Tate & Lyle regulatory calendar, and post-closing leverage.
Lower the rating if organic revenue declines, gross margin falls below roughly 22%, deal terms worsen, or debt to EBITDA climbs above about 3.5x after closing.
Investment research summary
Ingredion turns corn and other plant-based materials into starches, sweeteners, and texture and healthful ingredients that food, beverage, pharma, personal care, and industrial customers need for their products. Customers pay for functional properties such as mouthfeel and sweetness that are hard to replicate in-house.
The moat comes from scale in wet-milling assets, a global distribution network, long customer relationships, and recipe-level switching costs in specialty ingredients. Commodity segments such as corn syrup and industrial starch face intense competition from ADM, Cargill, and regional producers.
The thesis fails if the Tate & Lyle deal is blocked or integrates poorly, synergies fall short, corn prices spike and crush margins contract, organic growth stays near zero, or customers switch to alternative ingredients or in-house production. The 2025-2026 share decline shows the market already prices meaningful execution risk.
Chairman and CEO Jim Zallie has led a shift toward specialty and higher-margin ingredients. The roughly $3.6 billion all-cash offer for Tate & Lyle is the defining bet of his tenure. Management has kept the dividend rising, divested the Pakistan business for $165 million in June 2026, and added small bolt-on assets such as the Benicaros prebiotic fiber.
Specialty food ingredients are a mature, low-growth industry with structural sub-trends in clean label, sugar reduction, plant-based, and fortification. The Tate & Lyle deal adds scale in mouthfeel, sweetening, and fibers. This is a consolidation and value-mix story rather than a paradigm shift.
At about 9.5x trailing earnings with a 3.3% dividend yield and near 5.7% TTM free cash flow yield, INGR trades below the market and packaged food peers. The margin of safety depends on whether the discount reflects temporary pessimism or justified execution risk. The three-scenario model points to a base case near $132 over three years versus a bear case near $90.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| INGR price (most recent close) | $99.46 close on July 31, 2026 | WallStreetZen | July 31, 2026 |
| INGR price (delayed cross-check) | $102.71 close on July 28, 2026 | Yahoo Finance | July 28, 2026 |
| Market capitalization | $6.27 billion, verified as $99.46 x 63.06 million shares | financial_rigor.py market cap verification and WallStreetZen | July 31, 2026 |
| Shares outstanding | 63,059,061 | WallStreetZen | July 31, 2026 |
| TTM revenue | $7.2 billion (2025 net sales of about $7.2 billion) | Yahoo Finance statistics and Ingredion press release | July 28, 2026 |
| TTM net income | $674 million | Yahoo Finance statistics | July 28, 2026 |
| TTM diluted EPS | $10.53 (WallStreetZen lists $10.55) | Yahoo Finance and WallStreetZen | July 28, 2026 |
| TTM levered free cash flow | $357.75 million | Yahoo Finance statistics | July 28, 2026 |
| Cash and equivalents | $918 million | Yahoo Finance balance sheet | July 28, 2026 |
| Total debt/equity | 41.43% before the pending deal | Yahoo Finance statistics | July 28, 2026 |
| Dividend and yield | $3.28 per share, about 3.30% yield | Yahoo Finance statistics | July 28, 2026 |
| Valuation math | 9.45x TTM PE, 1.43x PB, 17.54x P/FCF, 5.70% FCF yield from financial_rigor.py | financial_rigor.py valuation verification | July 31, 2026 |
| 52-week range | $94.44 to $134.77 (Yahoo); high $130.48 (WallStreetZen) | Yahoo Finance and WallStreetZen | July 28, 2026 |
| Analyst 12-month price target | Average $121.17 (Yahoo) and $123.60 (WallStreetZen, range $120 to $130) | Yahoo Finance and WallStreetZen | July 31, 2026 |
| Tate & Lyle offer | 595 pence per share all-cash, reported about $3.6 billion; accepted by shareholders July 28, 2026 | GlobeNewswire release and Reuters | July 28, 2026 |
This INGR AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast ranges are scenarios based on data available as of August 4, 2026 and can be wrong.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
